GlassScriptPhysician profile
Azhar U Khan
NPI 1821054453
$6,696.30
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,603 · 2020: $2,206 · 2021: $1,887.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,099.77 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $885.32 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $785.63 | 2019-2021 | |
| Veran Medical Technologies, INC. | $585.41 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $493.15 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $444.26 | 2019-2021 | |
| Fisher & Paykel Healthcare INC | $334.96 | 2019-2021 | |
| Genentech USA, INC. | $290.36 | 2019-2020 | |
| Genzyme Corporation | $260.25 | 2019-2021 | |
| Advanced Respiratory, INC | $245.53 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $231.91 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $138.42 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.80 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $99.60 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $82.19 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $73.86 | 2019-2020 | |
| Electromed, INC. | $67.63 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $67.01 | 2019-2020 | |
| Mylan Specialty L.P. | $53.91 | 2019-2020 | |
| Pfizer INC. | $52.05 | 2019 | |
| Livanova USA, INC. | $48.77 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $42.31 | 2020 | |
| Shire North American Group INC | $35.80 | 2019 | |
| Sunovion Pharmaceuticals INC. | $34.07 | 2019-2020 | |
| Philips North America LLC | $32.95 | 2020 | |
| Amgen INC. | $24.58 | 2021 | |
| United Therapeutics Corporation | $22.44 | 2021 | |
| Mallinckrodt Hospital Products INC. | $21.73 | 2020 | |
| Pulmonx Corporation | $18.05 | 2020 | |
| Insmed, INC. | $15.58 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azhar Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.